NCT06568835

Brief Summary

The goal of this clinical trial is to discuss the effects of physical activity on nutrition, inflammation, muscle metabolism, and the occurrence of cardiovascular and cerebrovascular events in patients with maintenance haemodialysis. The main question it aims to answer is: can exercise improve nutritional and inflammatory status, enhance muscle strength, and reduce the incidence of cardiovascular and cerebrovascular events in patients with maintenance haemodialysis. Researchers will compared active exercise group to conventional treatment group to see the impact of exercise on maintenance haemodialysis patients. Participants will: Choose low-intensity aerobic exercise workouts such as walking (no less than 8,000 steps per day) or jogging, swimming, Tai Chi, etc., according to their individual conditions, for no less than 30 minutes at a time, at least 3 times per week, and the intensity of the exercise should be based on an RPE score of 12 to 16.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 31, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

August 23, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

August 23, 2024

Status Verified

August 1, 2024

Enrollment Period

1.5 years

First QC Date

July 31, 2024

Last Update Submit

August 21, 2024

Conditions

Keywords

ExerciseInflammationNutritionMuscular Atrophy

Outcome Measures

Primary Outcomes (6)

  • Mid-upper arm circumference of the non-internal fistula side(AC)

    Measure the circumference of the non-internal fistula at the midpoint of the upper arm using a soft tape measure, in centimetres

    Baseline and half year, 1 year

  • triceps skin-fold thickness of the non-internal fistula side(TSF)

    Measurement of the skinfold at the midpoint of the upper arm on the non-internal fistula side by using a skinfold thickness gauge, in centimetres

    Baseline and half year, 1 year

  • upper arm muscle circumference of the non-internal fistula side(AMC)

    AMC(cm)= AC(cm) - 3.14 x TSF(cm)

    Baseline and half year, 1 year

  • calf circumference

    Measure the calf circumference using a soft tape measure, in centimetres

    Baseline and half year, 1 year

  • grip strength

    Using a grip strength meter, with the patient seated and gripping the handle firmly with the palm of the non-internal fistulae side, measure twice and record the maximum grip strength value

    Baseline and half year, 1 year

  • Incidence of cardiovascular and cerebrovascular events

    Cardiovascular events include: heart failure episodes, sustained arrhythmias, myocardial infarction, and cerebrovascular events include: cerebral haemorrhage, cerebral infarction, transient ischaemic attack.

    1 year

Secondary Outcomes (5)

  • prealbumin

    Baseline and half year, 1 year

  • albumin

    Baseline and half year, 1 year

  • haemoglobin

    Baseline and half year, 1 year

  • blood lipids

    Baseline and half year, 1 year

  • c-reactive protein

    Baseline and half year, 1 year

Study Arms (2)

exercise group

EXPERIMENTAL

patients were asked to choose walking (no less than 8000 steps per day) or low-intensity aerobic exercise such as jogging, swimming, Tai Chi, etc., according to their own conditions, for no less than 30 minutes each time, at least 3 times per week, and the intensity of the exercise was determined by the need to increase the frequency and depth of breathing during the exercise, and it was appropriate to feel slightly tired but not exhausted (RPE score 12-16). Exercise intensity should be at least 3 times a week, and the exercise intensity should be at a level that requires an increase in breathing rate and depth, allowing for dialogue and communication, slight sweating, and a feeling of being slightly tired but not exhausted (RPE score of 12 to 16).

Behavioral: exercise

Control group

NO INTERVENTION

only receive conventional MHD treatment, no requirement for exercise.

Interventions

exerciseBEHAVIORAL

such as walking, jogging, swimming, Tai Chi, etc. It needs to be at a certain frequency and intensity

exercise group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • MHD more than 3 months, 3 times per week, 3-4h each time;
  • Urea clearance index (Kt/V) \>1.2;
  • Stable condition, no serious infection, tumour and cardiovascular disease;
  • Willing to join the study and sign the informed consent form.

You may not qualify if:

  • Combined with serious heart and lung disease: such as repeated heart failure, severe arrhythmia, unstable angina pectoris, severe pericardial effusion, severe heart valve disease, hypertrophic cardiomyopathy, aortic coarctation, severe emphysema, pulmonary heart disease, severe pulmonary hypertension (average pressure of the pulmonary artery \> 55mmHg), etc.;
  • Combined with chronic joints, muscles, or vascular disease can not be or is not suitable for regular exercise, such as cerebrovascular disease; combined chronic joint, muscle or vascular disease can not or are not suitable for regular exercise, such as cerebrovascular disease sequelae, serious lower limb joint damage, severe myopathy, deep vein thrombosis, etc.;
  • unwilling to cooperate with the movement of people

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400016, China

RECRUITING

MeSH Terms

Conditions

Motor ActivityInflammationMuscular Atrophy

Interventions

Exercise

Condition Hierarchy (Ancestors)

BehaviorPathologic ProcessesPathological Conditions, Signs and SymptomsNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalSigns and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Active exercise group: patients were asked to choose walking (no less than 8000 steps per day) or low-intensity aerobic exercise such as jogging, swimming, Tai Chi, etc., according to their own conditions, for no less than 30 minutes each time, at least 3 times per week, and the intensity of the exercise was determined by the need to increase the frequency and depth of breathing during the exercise, and it was appropriate to feel slightly tired but not exhausted (RPE score 12-16). Exercise intensity should be at least 3 times a week, and the exercise intensity should be at a level that requires an increase in breathing rate and depth, allowing for dialogue and communication, slight sweating, and a feeling of being slightly tired but not exhausted (RPE score of 12 to 16). Control group: only receive conventional MHD treatment, no requirement for exercise.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

July 31, 2024

First Posted

August 23, 2024

Study Start

January 1, 2024

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

August 23, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations